Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

    PCR of TCR/Ig gene rearrangements is considered the method of choice for minimal residual disease (MRD) quantification in BCP-ALL, but flow cytometry analysis of leukemia-associated immunophenotypes (FCM-MRD) ...

    S. Modvig, H. Hallböök, H. O. Madsen, S. Siitonen, S. Rosthøj, A. Tierens in Leukemia (2021)

  2. Article

    Correction: Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens

    A Correction to this paper has been published: https://doi.org/10.1038/s41409-021-01257-2

    A. B. Versluys, J. J. Boelens, C. Pronk, A. Lankester in Bone Marrow Transplantation (2021)

  3. No Access

    Article

    Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens

    The impact of conditioning regimen prior to hematopoietic cell transplant (HCT) in pediatric AML-patients is not well studied. We retrospectively analyzed the impact of Busulfan–Cyclophosphamide (BuCy), Busulf...

    A. B. Versluys, J. J. Boelens, C. Pronk, A. Lankester in Bone Marrow Transplantation (2021)

  4. Article

    Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen in Leukemia (2020)

  5. No Access

    Article

    T-cell acute lymphoblastic leukemia in patients 1–45 years treated with the pediatric NOPHO ALL2008 protocol

    The NOPHO ALL2008 is a population-based study using an unmodified pediatric protocol in patients 1–45 years of age with acute lymphoblastic leukemia. Patients with T-ALL were given a traditional pediatric sche...

    P. Quist-Paulsen, N. Toft, M. Heyman, J. Abrahamsson, L. Griškevičius in Leukemia (2020)

  6. No Access

    Article

    Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

    Minimal residual disease (MRD) measured by PCR of clonal IgH/TCR rearrangements predicts relapse in T-cell acute lymphoblastic leukemia (T-ALL) and serves as risk stratification tool. Since 10% of patients hav...

    S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen in Leukemia (2019)

  7. No Access

    Article

    Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

    Adults with acute lymphoblastic leukemia (ALL) do worse than children. From 7/2008 to 12/2014, Nordic and Baltic centers treated 1509 consecutive patients aged 1–45 years with Philadelphia chromosome-negative ...

    N Toft, H Birgens, J Abrahamsson, L Griškevičius, H Hallböök, M Heyman in Leukemia (2018)

  8. No Access

    Article

    Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients

    K Lähteenmäki, P Wacklin, M Taskinen, E Tuovinen, O Lohi in Bone Marrow Transplantation (2017)

  9. No Access

    Article

    Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group

    Fertility preservation is an urgent challenge in the transplant setting. A panel of transplanters and fertility specialists within the Pediatric Diseases Working Party of the European Society for Blood and Mar...

    A Balduzzi, J-H Dalle, K Jahnukainen, M von Wolff in Bone Marrow Transplantation (2017)

  10. No Access

    Article

    State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29–30 September 2015

    Nowadays, allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a well-established treatment procedure and often the only cure for many patients with malignant and non-malignant diseases. Decrease...

    J-H Dalle, G Lucchini, A Balduzzi, M Ifversen, K Jahnukainen in Bone Marrow Transplantation (2017)

  11. No Access

    Article

    Good responses but high TRM in adult patients after MSC therapy for GvHD

    U Salmenniemi, M Itälä-Remes, J Nystedt, M Putkonen in Bone Marrow Transplantation (2017)

  12. No Access

    Article

    Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters

    Younger children are considered to be more vulnerable to late effects (LE), which prompted us to study LE in patients after haematopoietic stem cell transplantation (HSCT) for a haematological malignancy befor...

    D Bresters, A Lawitschka, C Cugno, U Pötschger, A Dalissier in Bone Marrow Transplantation (2016)

  13. No Access

    Article

    Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

    M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, E I Andersson, Ø Bruserud in Leukemia (2014)

  14. No Access

    Article

    Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT

    Among the immunocompetent, infections with parvovirus B19 (B19V) and human bocavirus (HBoV) 1 range clinically from asymptomatic to severe, while following allogeneic hematopoietic SCT (HSCT) B19V can cause a ...

    J Rahiala, M Koskenvuo, P Norja, M Meriluoto, M Toppinen in Bone Marrow Transplantation (2013)

  15. No Access

    Article

    Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation

    K Jahnukainen, H Tinkanen, A Wikström, L Dunkel, U M Saarinen-Pihkala in Leukemia (2013)

  16. No Access

    Article

    Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases

    The purpose of this study was the appraisal of the clinical and functional consequences of germline mutations within the gene for the IL-2 inducible T-cell kinase, ITK. Among patients with Epstein-Barr virus-d...

    R M Linka, S L Risse, K Bienemann, M Werner, Y Linka, F Krux, C Synaeve in Leukemia (2012)

  17. No Access

    Article

    Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse

    Conflicting conclusions can be drawn from the available data concerning antileukemic efficacy and risks of intrathecal (i.t.) chemoprophylaxis to children after hematopoietic SCT (HSCT). To address this, we en...

    J Rubin, K Vettenranta, J Vettenranta, M Bierings in Bone Marrow Transplantation (2011)

  18. No Access

    Article

    Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT

    We present a set of tests for physical performance used for annual prospective follow-up after a pediatric transplant. Of the 103 eligible patients transplanted at a mean age of 8.8 years, 94 were included. Th...

    L Hovi, M Kurimo, M Taskinen, J Vettenranta, K Vettenranta in Bone Marrow Transplantation (2010)

  19. No Access

    Article

    The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse

    Drug doses, blood levels of drug metabolites and myelotoxicity during 6-mercaptopurine/methotrexate (MTX) maintenance therapy were registered for 59 adolescents (⩾10 years) and 176 non-adolescents (<10 years) ...

    K Schmiegelow, M Heyman, G Gustafsson, B Lausen, F Wesenberg, J Kristinsson in Leukemia (2010)

  20. No Access

    Article

    Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

    Myelotoxicity during thiopurine therapy is enhanced in patients, who because of single nucleotide polymorphisms have decreased activity of the enzyme thiopurine methyltransferase (TPMT) and thus more thiopurin...

    K Schmiegelow, E Forestier, J Kristinsson, S Söderhäll, K Vettenranta in Leukemia (2009)

previous disabled Page of 2